Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 298

Results For "RI"

10313 News Found

AstraZeneca requests Emergency Use Authorisation for drug to prevent Covid
Biotech | October 05, 2021

AstraZeneca requests Emergency Use Authorisation for drug to prevent Covid

The filing includes data from PROVENT Phase III trial showing 77% reduction in risk of developing symptomatic Covid-19 with a long-acting antibody combination (non-vaccine)


DentalMonitoring launches ScanBox, an AI-powered orthodontic care device
Medical Device | October 05, 2021

DentalMonitoring launches ScanBox, an AI-powered orthodontic care device

DentalMonitoring, the company that pioneered artificial intelligence in dental and orthodontic care, has announced the launch of the ScanBox


Moderna Science Centre coming up in Cambridge, MA
Biotech | October 04, 2021

Moderna Science Centre coming up in Cambridge, MA

The 462,000 square foot state-of-the-art building targeting LEED Zero certification and is designed to be the most sustainable commercial lab building in Cambridge


Lilly to transfer rights of two diabetes drugs to Cipla in India
Drug Approval | October 04, 2021

Lilly to transfer rights of two diabetes drugs to Cipla in India

Lilly will continue to maintain its existing operating model for the remaining portfolio of products


NITI Aayog launches report on best practices in district hospitals
Public Health | October 01, 2021

NITI Aayog launches report on best practices in district hospitals

A total of 707 district hospitals across all states and union territories participated in the performance assessment. The Health Management Information System (HMIS) data for the year 2017–18 has been used as a baseline for this exercise


Merck and Ridgeback’s molnupiravir offer hope to Covid-19 patients
Biotech | October 01, 2021

Merck and Ridgeback’s molnupiravir offer hope to Covid-19 patients

If cleared, Merck's drug would be the first pill shown to treat Covid-19, a potentially major advance in efforts to fight the pandemic


Lifebit Biotech raises US $ 60 m in Series B funding
Startup | September 30, 2021

Lifebit Biotech raises US $ 60 m in Series B funding

Lifebit's accompanying suite of AI-powered end-to-end software solutions provide faster data insights, accelerate drug discovery pipelines, and improve clinical trials success


Glenmark receives marketing approval for Ryaltris in 13 countries across the EU and UK
Drug Approval | September 30, 2021

Glenmark receives marketing approval for Ryaltris in 13 countries across the EU and UK

Ryaltris is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis


U.S. FDA approves Repatha for paediatric patients aged 10 years and older
Drug Approval | September 27, 2021

U.S. FDA approves Repatha for paediatric patients aged 10 years and older

The FDA also approved Repatha as an adjunct to other LDL-C lowering therapies for the treatment of homozygous familial hypercholesterolemia (HoFH) for younger pediatric patients


Fujifilm to verify effectiveness of AI technology in health screening services
Digitisation | September 27, 2021

Fujifilm to verify effectiveness of AI technology in health screening services

This project will be conducted at the “NURA,” a health screening centre that Fujifilm opened in India in February this year